2023 Q2 Form 10-Q Financial Statement

#000121390023039116 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $2.327M $2.810M $3.651M
YoY Change -30.9% -23.04% 49.7%
Cost Of Revenue $727.3K $947.2K $1.447M
YoY Change -46.7% -34.56% 46.28%
Gross Profit $1.600M $1.863M $2.203M
YoY Change -20.14% -15.47% 52.03%
Gross Profit Margin 68.75% 66.29% 60.36%
Selling, General & Admin $2.962M $2.879M $2.525M
YoY Change 23.89% 14.02% 73.05%
% of Gross Profit 185.14% 154.59% 114.6%
Research & Development $250.3K $313.9K $262.5K
YoY Change 22.32% 19.59% -16.38%
% of Gross Profit 15.64% 16.85% 11.91%
Depreciation & Amortization $210.0K $25.55K $194.4K
YoY Change 7.87% -86.86% -4.66%
% of Gross Profit 13.13% 1.37% 8.82%
Operating Expenses $3.876M $3.748M $3.487M
YoY Change 23.9% 7.51% 56.19%
Operating Profit -$2.276M -$1.886M -$1.283M
YoY Change 102.27% 46.97% 63.9%
Interest Expense $10.00K $52.43K
YoY Change -24.01%
% of Operating Profit
Other Income/Expense, Net $50.65K $52.43K
YoY Change 284.88%
Pretax Income -$2.268M -$1.833M -$1.283M
YoY Change 103.9% 42.89% -69.61%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.268M -$1.833M -$1.283M
YoY Change 103.9% 42.89% -69.61%
Net Earnings / Revenue -97.46% -65.25% -35.15%
Basic Earnings Per Share -$1.83 -$1.92 -$2.89
Diluted Earnings Per Share -$1.83 -$1.92 -$135.3K
COMMON SHARES
Basic Shares Outstanding 1.288M shares 24.41M shares 474.1K shares
Diluted Shares Outstanding 1.283M shares 996.1K shares 474.1K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.650M $9.782M $12.22M
YoY Change -31.35% -19.98% 43.56%
Cash & Equivalents $7.650M $9.782M $12.44M
Short-Term Investments
Other Short-Term Assets $660.0K $352.3K $1.104M
YoY Change -20.82% -68.07% 60.77%
Inventory $987.2K $1.134M $876.1K
Prepaid Expenses
Receivables $20.00K $50.68K $133.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.314M $11.32M $14.34M
YoY Change -27.57% -21.05% 42.66%
LONG-TERM ASSETS
Property, Plant & Equipment $253.5K $252.9K $269.3K
YoY Change 47.25% -6.11% -11.99%
Goodwill $10.96M $10.96M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.33M $16.14M $15.51M
YoY Change 3.92% 4.05% -25.56%
TOTAL ASSETS
Total Short-Term Assets $9.314M $11.32M $14.34M
Total Long-Term Assets $16.33M $16.14M $15.51M
Total Assets $25.64M $27.46M $29.85M
YoY Change -10.26% -8.01% -3.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $446.7K $521.3K $1.059M
YoY Change -43.35% -50.79% -54.04%
Accrued Expenses $850.0K $750.5K $658.4K
YoY Change 4.23% 14.0% -61.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.294M $1.272M $1.826M
YoY Change -21.59% -30.34% -70.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $410.0K $424.2K $367.4K
YoY Change 17.48% 15.46% -71.98%
Total Long-Term Liabilities $410.0K $424.2K $367.4K
YoY Change 17.48% 15.46% -91.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.294M $1.272M $1.826M
Total Long-Term Liabilities $410.0K $424.2K $367.4K
Total Liabilities $1.702M $1.696M $2.193M
YoY Change -14.89% -22.67% -79.29%
SHAREHOLDERS EQUITY
Retained Earnings -$89.71M -$87.44M
YoY Change 10.65%
Common Stock $133.00 $123.00
YoY Change -86.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.13M $23.96M $25.85M
YoY Change
Total Liabilities & Shareholders Equity $25.64M $27.46M $29.85M
YoY Change -10.26% -8.01% -3.36%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.268M -$1.833M -$1.283M
YoY Change 103.9% 42.89% -69.61%
Depreciation, Depletion And Amortization $210.0K $25.55K $194.4K
YoY Change 7.87% -86.86% -4.66%
Cash From Operating Activities -$1.820M -$1.383M $292.5K
YoY Change 143.99% -572.86% -129.16%
INVESTING ACTIVITIES
Capital Expenditures $40.00K $5.732K -$36.99K
YoY Change -128.42% -115.5%
Acquisitions
YoY Change
Other Investing Activities -$350.0K -$137.9K
YoY Change 29.98%
Cash From Investing Activities -$400.0K -$143.6K -$36.99K
YoY Change -2.44% 288.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K $4.331M -75.00K
YoY Change -206.67% -5874.91% -101.46%
NET CHANGE
Cash From Operating Activities -1.820M -$1.383M 292.5K
Cash From Investing Activities -400.0K -$143.6K -36.99K
Cash From Financing Activities 80.00K $4.331M -75.00K
Net Change In Cash -2.140M $2.805M 180.5K
YoY Change 73.85% 1454.19%
FREE CASH FLOW
Cash From Operating Activities -$1.820M -$1.383M $292.5K
Capital Expenditures $40.00K $5.732K -$36.99K
Free Cash Flow -$1.860M -$1.389M $329.4K
YoY Change 207.33% -521.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36616
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LogicMark, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0678374
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2801 Diode Lane
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Louisville
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
KY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
40299
CY2023Q1 dei City Area Code
CityAreaCode
(502)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
442-7911
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
LGMK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1287518 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9781799 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6977114 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
59988 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
59988 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
50679 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
402595 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1134497 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1745211 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
292319 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
349097 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
11319282 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9534005 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
252855 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
255578 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
164554 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
182363 usd
CY2023Q1 lgmk Product Development Costs Net Of Amortization
ProductDevelopmentCostsNetOfAmortization
15029 usd
CY2022Q4 lgmk Product Development Costs Net Of Amortization
ProductDevelopmentCostsNetOfAmortization
15029 usd
CY2023Q1 lgmk Product Development Costs
ProductDevelopmentCosts
1253749 usd
CY2022Q4 lgmk Product Development Costs
ProductDevelopmentCosts
1010662 usd
CY2023Q1 us-gaap Goodwill
Goodwill
10958662 usd
CY2022Q4 us-gaap Goodwill
Goodwill
10958662 usd
CY2023Q1 lgmk Other Intangible Assets Amortization
OtherIntangibleAssetsAmortization
4900886 usd
CY2022Q4 lgmk Other Intangible Assets Amortization
OtherIntangibleAssetsAmortization
4710437 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3509405 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3699854 usd
CY2023Q1 us-gaap Assets
Assets
27458507 usd
CY2022Q4 us-gaap Assets
Assets
25641124 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
521283 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
673052 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
750532 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1740490 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1271815 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2413542 usd
CY2023Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
424195 usd
CY2022Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
440263 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1696010 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2853805 usd
CY2023Q1 lgmk Preferred Stock Value1
PreferredStockValue1
1807300 usd
CY2022Q4 lgmk Preferred Stock Value1
PreferredStockValue1
1807300 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 lgmk Preferred Stock Value2
PreferredStockValue2
319000 usd
CY2022Q4 lgmk Preferred Stock Value2
PreferredStockValue2
520000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1220308 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1220308 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
479669 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
479669 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
123 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
48 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
111079795 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106070253 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87443721 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85610282 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23955197 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20980019 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27458507 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25641124 usd
CY2023Q1 us-gaap Revenues
Revenues
2809717 usd
CY2022Q1 us-gaap Revenues
Revenues
3650689 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
947169 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1447305 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1862548 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
2203384 usd
CY2023Q1 lgmk Direct Operating Cost
DirectOperatingCost
262800 usd
CY2022Q1 lgmk Direct Operating Cost
DirectOperatingCost
474442 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
48116 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
465536 usd
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
189207 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
313887 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
262484 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2413760 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2335949 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-28318 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-30084 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215998 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
194363 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3748415 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3486529 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1885867 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1283145 usd
CY2023Q1 lgmk Warrant Modification Expenses
WarrantModificationExpenses
-52428 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52428 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1833439 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1283145 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1833439 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1283145 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
75000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
88000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1908439 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1371145 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.92
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.89
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
996080 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
474099 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20980019 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
426842 usd
CY2023Q1 lgmk Shares Issued As Stock Compensation
SharesIssuedAsStockCompensation
2203 usd
CY2023Q1 lgmk Sale Of Common Stock And Warrants Pursuant To A Registration Statement On Form S1
SaleOfCommonStockAndWarrantsPursuantToARegistrationStatementOnFormS1
5211428 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-805245 usd
CY2023Q1 lgmk Series F Preferred Stock Dividends To Common Stock
SeriesFPreferredStockDividendsToCommonStock
48389 usd
CY2023Q1 lgmk Series C Preferred Stock Dividends
SeriesCPreferredStockDividends
75000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1833439 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23955197 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
26589171 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
512349 usd
CY2022Q1 lgmk Shares Issued As Stock Compensation
SharesIssuedAsStockCompensation
117453 usd
CY2022Q1 lgmk Series C Preferred Stock Dividends
SeriesCPreferredStockDividends
75000 usd
CY2022Q1 lgmk Series F Preferred Stock Dividends To Common Stock
SeriesFPreferredStockDividendsToCommonStock
-13000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1283145 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
25847828 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1833439 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1283145 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25549 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
257 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
429045 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
629802 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
190449 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194106 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-351916 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34513 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-610714 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-361196 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-56778 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
44198 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-229741 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
566983 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-984157 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-98041 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1382886 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
292447 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5732 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36988 usd
CY2023Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
137880 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143612 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36988 usd
CY2023Q1 lgmk Termination Fee Upon Early Payment Of Term Loan
TerminationFeeUponEarlyPaymentOfTermLoan
-5211428 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
805245 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
75000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
75000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4331183 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-75000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2804685 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
180459 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7037102 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12254546 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9841787 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12435005 usd
CY2022Q1 lgmk Accrued Preferred Stock Dividends
AccruedPreferredStockDividends
107933 usd
CY2023Q1 lgmk Conversion Of Series E Preferred Stock To Common Stocks
ConversionOfSeriesEPreferredStockToCommonStocks
201000 usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
48389 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
17094 usd
CY2023Q1 lgmk Website Development Included In Accounts Payabl
WebsiteDevelopmentIncludedInAccountsPayabl
105207 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6600000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1900000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1800000 usd
CY2023Q1 lgmk Cash And Cash Equivalents
CashAndCashEquivalents
9800000 usd
CY2023Q1 lgmk Working Capital
WorkingCapital
10000000 usd
CY2022Q4 lgmk Working Capital
WorkingCapital
7100000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock-based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the condensed financial statements and disclosures. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9200000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
60000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>CONCENTRATIONS OF CREDIT RISK</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2023Q1 lgmk Freight Charges
FreightCharges
100000 usd
CY2022Q1 lgmk Freight Charges
FreightCharges
200000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1100000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
60000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
600000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1200000 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
10000.00 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
200000 usd
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
200000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
600000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
800000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
600000 usd
CY2023Q1 us-gaap Amortization Expense Per Dollar Of Gross Revenue
AmortizationExpensePerDollarOfGrossRevenue
300000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
63000 usd
CY2023Q1 lgmk Stock Options To Purchase
StockOptionsToPurchase
36053 shares
CY2022Q1 lgmk Stock Options To Purchase
StockOptionsToPurchase
17434 shares
CY2023Q1 us-gaap Development Costs
DevelopmentCosts
200000 usd
CY2023Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
400000 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
300000 usd
CY2023Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
212247 usd
CY2022Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
114030 usd
CY2023Q1 lgmk Accrued Merchant Bank Fees
AccruedMerchantBankFees
18946 usd
CY2022Q4 lgmk Accrued Merchant Bank Fees
AccruedMerchantBankFees
15062 usd
CY2023Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
58100 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
25000 usd
CY2023Q1 lgmk Accrued Managements Incentives
AccruedManagementsIncentives
153800 usd
CY2022Q4 lgmk Accrued Managements Incentives
AccruedManagementsIncentives
519800 usd
CY2023Q1 lgmk Lease Liability
LeaseLiability
67660 usd
CY2022Q4 lgmk Lease Liability
LeaseLiability
69402 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48389 usd
CY2023Q1 us-gaap Inventory Adjustments
InventoryAdjustments
37141 usd
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
812970 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
202638 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
135837 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan
FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan
750532 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan
FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan
1740490 usd
CY2023Q1 us-gaap Partners Capital Account Units Treasury
PartnersCapitalAccountUnitsTreasury
3440000 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.02
CY2023Q1 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
3440000 usd
CY2023Q1 lgmk Aggregate Share
AggregateShare
258000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
2.52 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
815198 shares
CY2023Q1 lgmk Shares Of Common Stock
SharesOfCommonStock
61140 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.52
CY2023Q1 lgmk Gross Proceeds
GrossProceeds
5200000 usd
CY2023Q1 lgmk Percentage Of Underwriting Discounts And Commissions
PercentageOfUnderwritingDiscountsAndCommissions
0.07 pure
CY2023Q1 lgmk Percentage Of Gross Proceeds
PercentageOfGrossProceeds
0.035 pure
CY2022Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
75000 usd
CY2023Q1 lgmk Voting Rights Description
VotingRightsDescription
One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3125 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
400000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1100000 usd
CY2022Q1 us-gaap Assets
Assets
300000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
1250 shares
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
400000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
600000 usd
CY2023Q1 lgmk Real Estate Lease Term Description
RealEstateLeaseTermDescription
The Company’s real estate lease, which is for office space and a fulfillment center, with a lease term of 5 years expiring in August 2025. The Company also leases a copier with a lease term of 5 years, ending August 2023.
CY2023Q1 lgmk Monthly Rent Amount
MonthlyRentAmount
6400 usd
CY2023Q1 lgmk Increasing Annual Rent Percentage
IncreasingAnnualRentPercentage
0.03 pure
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
25400 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
24600 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65977 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
80000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
54400 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
200377 usd
CY2023Q1 lgmk Payment With Imputed Interest Premium
PaymentWithImputedInterestPremium
28623 usd
CY2023Q1 lgmk Total Present Value Of Future Minimum Lease Payments
TotalPresentValueOfFutureMinimumLeasePayments
171754 usd
CY2023Q2 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
24406155 shares
CY2022Q1 lgmk Warrant Modification Expenses
WarrantModificationExpenses
usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
996080 shares
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
usd
CY2022Q1 lgmk Termination Fee Upon Early Payment Of Term Loan
TerminationFeeUponEarlyPaymentOfTermLoan
usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2023Q1 lgmk Accrued Preferred Stock Dividends
AccruedPreferredStockDividends
usd
CY2022Q1 lgmk Conversion Of Series E Preferred Stock To Common Stocks
ConversionOfSeriesEPreferredStockToCommonStocks
usd
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q1 lgmk Website Development Included In Accounts Payabl
WebsiteDevelopmentIncludedInAccountsPayabl
usd
CY2023Q1 lgmk Finite Lived Intangible Assets Amortization Expense Rolling Year
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYear
2024
CY2023Q1 lgmk Finite Lived Intangible Assets Amortization Expense Rolling Year One
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearOne
2025
CY2023Q1 lgmk Finite Lived Intangible Assets Amortization Expense Rolling Years Two
_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearsTwo
2026
CY2023Q1 lgmk Finite Lived Intangible Assets Amortization Expense Rolling Years Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearsThree
2027
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001566826

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-23-039116-index-headers.html Edgar Link pending
0001213900-23-039116-index.html Edgar Link pending
0001213900-23-039116.txt Edgar Link pending
0001213900-23-039116-xbrl.zip Edgar Link pending
f10q0323ex31-1_logicmark.htm Edgar Link pending
f10q0323ex31-2_logicmark.htm Edgar Link pending
f10q0323ex32-1_logicmark.htm Edgar Link pending
f10q0323ex32-2_logicmark.htm Edgar Link pending
f10q0323_logicmark.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
lgmk-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
lgmk-20230331_cal.xml Edgar Link unprocessable
lgmk-20230331_def.xml Edgar Link unprocessable
lgmk-20230331_lab.xml Edgar Link unprocessable
lgmk-20230331_pre.xml Edgar Link unprocessable
f10q0323_logicmark_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending